Search results for "GUT"

showing 10 items of 605 documents

Helminths, hosts, and their microbiota: new avenues for managing gastrointestinal helminthiases in ruminants

2020

Evidence is emerging of complex interactions occurring between gastrointestinal (GI) parasites of ruminants and the resident gut flora, with likely implications for the pathophysiology of worm infection and disease. Similarly, recent data point toward the occurrence of a GI nematode (GIN)-specific microbiota, with potential roles in worm fundamental physiology and reproduction. Parasite-microbiota relationships might represent potential targets for the development of novel parasiticides.In this article, we review current knowledge of the role(s) that host- and helminth-associated microbiota play in ruminant host-parasite relationships, and outline potential avenues for the control of GIN of…

0301 basic medicineMicrobiology (medical)030106 microbiologyGut floraMicrobiologyHost-Parasite InteractionsMicrobiology03 medical and health sciences0302 clinical medicineDrug DevelopmentHelminthsVirologyparasitic diseasesAnimalsHelminths030212 general & internal medicineMicrobiomeAnthelminticsbiologyProbioticsGastrointestinal MicrobiomeRuminantsbiology.organism_classificationGastrointestinal MicrobiomePrebioticsInfectious DiseasesDrug developmentHelminthiasis AnimalHaemonchus contortusExpert Review of Anti-infective Therapy
researchProduct

The Gut Entomotype of Red Palm Weevil Rhynchophorus ferrugineus Olivier (Coleoptera: Dryophthoridae) and Their Effect on Host Nutrition Metabolism

2017

For invasive insects, the potential roles of gut microbiota in exploiting new food resources and spreading remain elusive. Red palm weevil (RPW), Rhynchophorus ferrugineus Olivier, is an invasive destructive pest which feeds on nutrient-poor tender tissues and has caused extensive mortality of palm trees. The microbes associated with insects can improve their nutrition assimilation. However, experimental evidence on the interactions between RPW and its gut microbiota is still absent. The aim of this study is to determine the dynamics changes and the bacterial entomotype in the RPW gut and its potential physiological roles. Here, we confirmed RPW harbors a complex gut microbiota mainly const…

0301 basic medicineMicrobiology (medical)030106 microbiologylcsh:QR1-502Gut floraMicrobiologySerratiadigestive systemRhynchophorus ferrugineuslcsh:MicrobiologyMicrobiology03 medical and health sciencescellulose degradationHemolymphinsect symbiosissymbiotic invasionLarvabiologygut microbiotaWeevilfungibiology.organism_classificationEnterobacteriaceaeRhynchophorus030104 developmental biologyPEST analysisFrontiers in Microbiology
researchProduct

H89 Treatment Reduces Intestinal Inflammation and Candida albicans Overgrowth in Mice

2020

Deregulation of the dynamic crosstalk between the gut microbiota, intestinal epithelial cells, and immune cells is critically involved in the development of inflammatory bowel disease and the overgrowth of opportunistic pathogens, including the human opportunistic fungus Candida albicans. In the present study, we assessed the effect of N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H89), a protein kinase A inhibitor, on the migration of macrophages to C. albicans through dextran sulphate sodium (DSS)-challenged Caco-2 cells. We also investigated the impact of H89 on intestinal inflammation and C. albicans clearance from the gut, and determined the diversity of the gut microbio…

0301 basic medicineMicrobiology (medical)<i>Lactobacillus johnsonii</i>colitisH89030106 microbiologyInflammationGut floraMicrobiologydigestive systemArticleMicrobiology03 medical and health sciences<i>Enterococcus faecalis</i>Immune system[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesVirologyCandida albicansmedicineEscherichia coliEnterococcus faecalismicrobiotaColitisCandida albicanslcsh:QH301-705.5Lactobacillus johnsoniiLactobacillus johnsoniiDSSH89;Candida albicans;Escherichia coli;Enterococcus faecalis;Lactobacillus johnsonii;microbiota;DSS;colitis;protein kinase AInnate immune systembiology<i>Escherichia coli</i>[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterologymedicine.diseasebiology.organism_classificationCorpus albicans3. Good health<i>Candida albicans</i>030104 developmental biologylcsh:Biology (General)[SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacologyprotein kinase Amedicine.symptomMicroorganisms
researchProduct

The Presence or Absence of Intestinal Microbiota Affects Lipid Deposition and Related Genes Expression in Zebrafish (Danio rerio)

2018

Understanding how intestinal microbiota alters energy homeostasis and lipid metabolism is a critical process in energy balance and health. However, the exact role of intestinal microbiota in the regulation of lipid metabolism in fish remains unclear. Here, we used two zebrafish models (germ-free and antibiotics-treated zebrafish) to identify the role of intestinal microbiota in lipid metabolism. Conventional and germ-free zebrafish larvae were fed with egg yolk. Transmission electron microscopy was used to detect the presence of lipid droplets in the intestinal epithelium. The results showed that, microbiota increased lipid accumulation in the intestinal epithelium. The mRNA sequencing tech…

0301 basic medicineMicrobiology (medical)CD36lcsh:QR1-502BiologyGut floraACSL5Microbiologylcsh:Microbiology03 medical and health sciences0302 clinical medicineLipid dropletantibioticlipid metabolismZebrafishOriginal Researchgut microbiotaLipid metabolismbiology.organism_classificationzebrafishIntestinal epitheliumCell biology030104 developmental biologyMRNA Sequencinggerm-freebiology.protein030217 neurology & neurosurgeryFrontiers in Microbiology
researchProduct

The Gut Microbiota in Cardiovascular Disease and Arterial Thrombosis

2019

The gut microbiota has emerged as a contributing factor in the development of atherosclerosis and arterial thrombosis. Metabolites from the gut microbiota, such as trimethylamine N-oxide and short chain fatty acids, were identified as messengers that induce cell type-specific signaling mechanisms and immune reactions in the host vasculature, impacting the development of cardiovascular diseases. In addition, microbial-associated molecular patterns drive atherogenesis and the microbiota was recently demonstrated to promote arterial thrombosis through Toll-like receptor signaling. Furthermore, by the use of germ-free mouse models, the presence of a gut microbiota was shown to influence the syn…

0301 basic medicineMicrobiology (medical)CellDiseaseReview030204 cardiovascular system & hematologyGut floraarterial thrombosisMicrobiologydigestive systemlaw.invention03 medical and health sciencesProbiotic0302 clinical medicinelawcardiovascular diseaseVirologyMedicinevascular inflammationbiologygut microbiotabusiness.industryCell adhesion moleculeblood pressure regulationReceptor signalingbiology.organism_classificationmedicine.diseaseThrombosis030104 developmental biologymedicine.anatomical_structureImmunologyImmune reactionbusinessMicroorganisms
researchProduct

2017

Abstract A characterization of the bacterial community of the hindgut wall of two larval and the adult stages of the forest cockchafer (Melolontha hippocastani) was carried out using amplicon sequencing of the 16S rRNA gene fragment. It was found that, in second-instar larvae, Caulobacteraceae and Pseudomonaceae showed the highest relative abundances, while in third-instar larvae, the dominant families were Porphyromonadaceae and Bacteroidales-related. In adults, an increase of the relative abundance of Bacteroidetes, Proteobacteria (γ- and δ- classes) and the family Enterococcaceae (Firmicutes) was observed. This suggests that the composition of the hindgut wall community may depend on the…

0301 basic medicineMicrobiology (medical)CockchaferbiologyFirmicutes030106 microbiologyPorphyromonadaceaeBacteroidetesHindgutbiology.organism_classificationMicrobiologyMicrobiology03 medical and health sciences030104 developmental biologyAlcaligenaceaeProteobacteriaBacteriaFrontiers in Microbiology
researchProduct

Functional Redundancy-Induced Stability of Gut Microbiota Subjected to Disturbance.

2016

The microbiota should be considered as just another component of the human epigenetic landscape. Thus, health is also a reflection of the diversity and composition of gut microbiota and its metabolic status. In defining host health, it remains unclear whether diversity is paramount, or whether greater weight is held by gut microbiota composition or mono- or multiple-functional capacity of the different taxa and the mechanisms involved. A network-biology approach may shed light on the key gut players acting to protect against, or promote, disorders or diseases. This could be achieved by integrating data on total and active species, proteins and molecules, and their association with host resp…

0301 basic medicineMicrobiology (medical)Gastrointestinal Diseases030106 microbiologyHost responseGut floradigestive systemMicrobiology03 medical and health sciencesVirologymedicineAnimalsHumansEpigeneticsbiologyEcologyFunctional redundancyGastrointestinal MicrobiomeBiodiversitybiology.organism_classificationmedicine.diseaseBiotaGastrointestinal MicrobiomeGastrointestinal Tract030104 developmental biologyInfectious DiseasesDisturbance (ecology)Evolutionary biologyDysbiosisTrends in microbiology
researchProduct

How can the gut microbiota affect immune recovery in HIV-infected individuals?

2017

0301 basic medicineMicrobiology (medical)Microbial ConsortiaInflammationHIV InfectionsGut floraAffect (psychology)Microbiology03 medical and health sciencesMetabolomicsImmunityRNA Ribosomal 16SmedicineMetabolomeHumansMetabolomicsInflammationbiologyBacteriaImmunityRNARibosomal RNAbiology.organism_classification030112 virologyGastrointestinal Microbiome030104 developmental biologyPrebioticsImmunologyHIV-1Metabolomemedicine.symptomBiomarkersFuture microbiology
researchProduct

Time Series Analysis of the Microbiota of Children Suffering From Acute Infectious Diarrhea and Their Recovery After Treatment

2018

WOS: 000434952800001

0301 basic medicineMicrobiology (medical)Rotavirusmedicine.medical_specialtytemporal analysis030106 microbiologylcsh:QR1-502acute infectious diarrheaDiseaseGut floramedicine.disease_causeMicrobiologylcsh:Microbiologylaw.invention03 medical and health sciencesProbioticAcute infectious diarrhealawInternal medicineRotavirusmedicinemicrobiotaFecesOriginal Researchbiologybusiness.industryMicrobiotasystems biologyTemporal analysisbiology.organism_classificationmedicine.diseaseDiarrhea030104 developmental biologyrotavirusmedicine.symptombusinessSystems biologyDysbiosisSaccharomyces boulardiiFrontiers in Microbiology
researchProduct

Gut Microbiome Associates With Lipid-Lowering Effect of Rosuvastatin in Vivo

2018

Source at https://doi.org/10.3389/fmicb.2018.00530 . Background: Statin has been widely used to treat hyperlipidemia because of its high potency in decreasing cholesterol levels. The present study aimed to examine the lipid-lowering effect of rosuvastatin and the composition, diversity and species abundance of gut microbiome in association with rosuvastatin efficacy. TRIAL REGISTRATION: ChiCTR-ORC-17013212 at the First Affiliated Hospital of Dalian Medical University, November 2, 2017. Results:Totally 64 patients with hyperlipidemia were treated with 10 mg/day of rosuvastatin for 4-8 weeks. Blood lipid indicators triglycerides (TG), total cholesterol (TC), high density lipoprotein (HDL), lo…

0301 basic medicineMicrobiology (medical)Statinmedicine.drug_classlcsh:QR1-502PhysiologyBlood lipidsgut microbiomeBiologyGut floraMicrobiologylcsh:Microbiology03 medical and health scienceschemistry.chemical_compoundHigh-density lipoproteinHyperlipidemiamedicinehyperlipidemiaRosuvastatinVDP::Medical disciplines: 700::Clinical medical disciplines: 750::Cardiology: 771VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Kardiologi: 771CholesterolVDP::Medical disciplines: 700::Basic medical dental and veterinary science disciplines: 710::Pharmacology: 728nutritional and metabolic diseasesFusobacteriaVDP::Medical disciplines: 700::Basic medical dental and veterinary science disciplines: 710::Medical microbiology: 715medicine.diseasebiology.organism_classification16S rRNA sequencing030104 developmental biologychemistryVDP::Medisinske Fag: 700::Basale medisinske odontologiske og veterinærmedisinske fag: 710::Medisinsk mikrobiologi: 715VDP::Medisinske Fag: 700::Basale medisinske odontologiske og veterinærmedisinske fag: 710::Farmakologi: 728lipids (amino acids peptides and proteins)hypolipidemic effectrosuvastatinmedicine.drugFrontiers in Microbiology
researchProduct